MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1157/13110209

Медицинская библиотека · Medicina clinica · 2007

[Efficacy and safety of a reduced-dose of stavudine in HIV-infected patients under immunological and virological stable conditions].

Pedrol Enric, Martín Teodoro, del Pozo Miguel Angel, Flores Juan, Sanz José, Cartón José A, Jusdado Juan-José, Arazo Piedad, Ribera Esteve, Deig Elisabet, Grupo de Estudio de Evaluación del uso de Análogos de Nucleósidos

Аннотация на английскомСтатьяМногоцентровое исследованиеПеревод пока не подготовлен

Аннотация

BACKGROUND AND

OBJECTIVE

Stavudine (d4T) has shown a favourable short and long-term tolerability profile. Nevertheless, its usage is currently decreasing due to some safety concerns. We aimed to evaluate the efficacy and safety of d4T low-dose-based regimens.

PATIENTS AND METHOD: This was a multicenter and retrospective review chart of patients receiving standard doses of d4T for > or = 6 months (weight > 60 kg: 40 mg/12 h; weight < 60 kg: 30 mg/12 h) and having undetectable viral load for at least 3 months before the d4T dose reduction (weight > 60 kg: 30 mg/12 h; weight < 60 kg: 20 mg/12 h). Immunological and viral parametres, lipid profile and side effects were determined.

RESULTS

A total of 982 patients were included. The main reason for reducing the dose was prevention of toxicity (76%). After 6 months of follow-up, 97% and 84% patients had less than 400 and 50 cp/ml, respectively, and the CD4 cell count increased by 38 cel/ml. Lipids, lipodystrophy and peripheral polineuropathy improved but there was no statistical significance.

CONCLUSIONS

A d4T dose reduction in an immuno-virologically stable population does not affect treatment efficacy. Longer follow-ups are required to confirm improvements in the safety profile.

Для цитирования: Pedrol Enric, Martín Teodoro, del Pozo Miguel Angel, Flores Juan, Sanz José, Cartón José A, Jusdado Juan-José, Arazo Piedad, Ribera Esteve, Deig Elisabet, Grupo de Estudio de Evaluación del uso de Análogos de Nucleósidos. [Efficacy and safety of a reduced-dose of stavudine in HIV-infected patients under immunological and virological stable conditions].. Medicina clinica. 2007. DOI: 10.1157/13110209.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.